0001209191-18-064322.txt : 20181228
0001209191-18-064322.hdr.sgml : 20181228
20181228163459
ACCESSION NUMBER: 0001209191-18-064322
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181226
FILED AS OF DATE: 20181228
DATE AS OF CHANGE: 20181228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vertex Pharmaceuticals (Europe) Ltd
CENTRAL INDEX KEY: 0001761216
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 181257746
BUSINESS ADDRESS:
STREET 1: 2 KINGDOM STREET, 9TH FLOOR
CITY: LONDON
STATE: X0
ZIP: W2 6BD
BUSINESS PHONE: 617-341-6100
MAIL ADDRESS:
STREET 1: 2 KINGDOM STREET, 9TH FLOOR
CITY: LONDON
STATE: X0
ZIP: W2 6BD
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 181257747
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-26
0
0001674416
CRISPR Therapeutics AG
CRSP
0001761216
Vertex Pharmaceuticals (Europe) Ltd
2 KINGDOM ST., 9TH FLOOR
LONDON
X0
W2 6BD
UNITED KINGDOM
0
0
1
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
50 NORTHERN AVENUE
BOSTON
MA
02210
0
0
1
0
Common Shares
2018-12-26
4
P
0
12737
24.8942
A
5353479
D
Common Shares
2018-12-27
4
P
0
27461
24.9487
A
5380940
D
Shares are directly held by Vertex Pharmaceuticals (Europe) Limited ("Vertex Europe"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe.
Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.69 and $25.00.
Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.85 and $25.00.
/s/ Ian F. Smith, on behalf of Vertex Pharmaceuticals (Europe) Limited
2018-12-28
/s/ Ian F. Smith, on behalf of Vertex Pharmaceuticals Inc.
2018-12-28